Home » Authors » Kim Coghill

Articles by Kim Coghill

Washington Debates Pros, Cons Of Drug Importation

April 15, 2004

Washington Debates Pros, Cons Of Drug Importation

April 15, 2004

Acambis Suspends Enrollment In Smallpox Vaccine Pivotal Program

April 14, 2004

Government contractor Acambis plc suspended recruitment of additional volunteers in a Phase III program evaluating its smallpox vaccine candidate against Dryvax, after three out of 2,800 participants showed signs of heart inflammation. (BioWorld Today)

Acambis Suspends Enrollment In Smallpox Vaccine Pivotal Program

April 14, 2004

Government contractor Acambis plc suspended recruitment of additional volunteers in a Phase III program evaluating its smallpox vaccine candidate against Dryvax, after three out of 2,800 participants showed signs of heart inflammation. (BioWorld Today)

Cetek $16M Series D Round Brings Total Raised To $50M

April 13, 2004

Cetek $16M Series D Round Brings Total Raised To $50M

April 13, 2004

Legislation Would Give More Firms Access To SBIR Grants

April 12, 2004

Legislation Would Give More Firms Access To SBIR Grants

April 12, 2004

Unigene Receiving Up To $18.7M In Novartis Calcitonin Agreement

April 9, 2004

Unigene Receiving Up To $18.7M In Novartis Calcitonin Agreement

April 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...